Search

everythinglearnresearchcommunity

for

Search:↓

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Trichoscopy helps accurately diagnose temporal triangular alopecia.

5-ARI therapy may help prevent prostate cancer progression.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

A rare biotin deficiency in an Iraqi family caused severe symptoms but was successfully treated with lifelong biotin.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Newborn screening for biotinidase deficiency is effective in preventing severe complications.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Burn reconstruction is crucial for improving long-term outcomes for burn survivors.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

A girl with citrullinemia developed pili torti, suggesting a link between the hair condition and the metabolic disorder.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

A girl with Rapunzel syndrome had surgery to remove a hairball, and addressing mental health is important to prevent it from happening again.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.